TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T22436 XX ID T22436 XX DT 22.08.2006 (created); jul. DT 24.08.2006 (updated); jul. CO Copyright (C), QIAGEN. XX FA IkappaB-epsilon-xxb2 XX SY IKBE; NFKBIE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G003378 NFKBIE; HGNC: NFKBIE. XX CL C0020; Rel. XX SZ 500 AA; 52.9 kDa (cDNA) (calc.). XX SQ MNQRRSESRPGNHRLQAYAEPGKGDSGGAGPLSGSARRGRGGGGAIRVRRPCWSGGAGRG SQ GGRPWAVRLPTVTAGWTWPALRTLSSLRAGPSEPHSPGRRRPRAGRPLCQADPQPGKAAR SQ RSLEPDPAQTGPRPARAAGMSEARKGPDEAEESQYDSGIESLRSLRSLPESTSAPASGPS SQ DGSPQPCTHPPGPVKEPQEKEDADGERADSTYGSSSLTYTLSLLGGPEAEDPPPRLPLPH SQ VGALSPQQLEALTYISEDGDTLVHLAVIHEAPAVLLCCLALLPQEVLDIQNNLYQTALHL SQ AVHLDQPGAVRALVLKGASRALQDRHGDTALHVACQRQSWPVPAACWKGGPEPGRGTSHS SQ LDLQLQNWQGLACLHIATLQKNQPLMELLLRNGADIDVQEGSSGKTALHLAVETQERGLV SQ QFLLQAGAQVDARMLNGCTPLHLAAGRGLMGISSTLCKAGADSLLRNVEDETPQDLTEES SQ LVLLPFDDLKISGKLLLCTD XX SC ref id [1] XX FT 258 288 SM00248; ANK_2a. FT 258 292 PF00023; Ank. FT 258 473 PS50297; ANK_REP_REGION. FT 293 322 SM00248; ANK_2a. FT 293 325 PF00023; Ank. FT 326 342 PF00023; Ank. FT 369 398 SM00248; ANK_2a. FT 369 401 PF00023; Ank. FT 369 401 PS50088; ANK_REPEAT. FT 403 432 SM00248; ANK_2a. FT 403 435 PF00023; Ank. FT 403 435 PS50088; ANK_REPEAT. FT 436 465 SM00248; ANK_2a. FT 436 468 PF00023; Ank. FT 436 468 PS50088; ANK_REPEAT. XX IN T00169 c-Rel; mouse, Mus musculus. IN T00394 NF-kappaB2-p52; human, Homo sapiens. IN T00595 RelA-p65; mouse, Mus musculus. XX DR TRANSPATH: MO000085468. DR UniProtKB: O00221; XX RN [1]; RE0013471. RX PUBMED: 9135156. RA Whiteside S. T., Epinat J. C., Rice N. R., Israel A. RT I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. RL EMBO J. 16:1413-1426 (1997). XX //